Photo by aaronburden from unsplash
A randomised controlled pilot study was performed to compare the clinical effectiveness of cyclosporine and methotrexate, using a new objective severity assessment method, which we then compared with the Psoriasis… Click to show full abstract
A randomised controlled pilot study was performed to compare the clinical effectiveness of cyclosporine and methotrexate, using a new objective severity assessment method, which we then compared with the Psoriasis Area Severity Index (PASI) for usefulness and reliability. Psoriatic patients with psoriatic lesions over 5% of body surface area were enrolled and underwent 16 weeks of treatment with either cyclosporine or methotrexate. In the cyclosporine group, the initial dose was 150 mg/day for females and 200 mg/day for males. This article is protected by copyright. All rights reserved.
Journal Title: British Journal of Dermatology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!